Filter
985
Text search:
clinical
algorithm
Featured
159
263
Language
Document type
489
238
126
72
22
21
9
5
2
Countries
74
38
34
32
29
29
19
19
18
18
18
15
13
12
11
10
10
10
9
8
8
8
8
7
7
6
6
6
6
6
6
5
5
4
4
4
4
4
4
3
3
3
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
390
147
54
39
26
16
14
Toolboxes
142
117
63
61
56
34
33
21
19
18
15
13
11
10
8
6
6
5
5
5
4
3
2
2
National Tuberculosis and Leprosy Control Program
UGANDA NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME
Policy framework.
Direct acting antivirals (DAAs) have revolutionized treatment for hepatitis C. Combi-
nations of DAAs can cure infection with HCV in 12 weeks, are highly effective and
have limited side-effects. Affordability of DAAs has improved significantly, but access remains lim-
i
...
The World Health Organization organized a Consultation of National Leprosy Programme managers, partners and affected persons to discuss the draft Global Leprosy Strategy, 2021--2030. This virtual event took place from 26 to 30 October 2020. It was attended by more than 450 stakeholders. Contribution
...
What We Know, What We Don’t Know, and What We Need to Do
Information note.
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte ...
This information note provides a strategic overview of key implementation considerations for diagnostic integration using these devices, and is primarily intended for use by national laboratory services and TB, HIV, and hepatitis programme managers.
It may also be of inte ...
A compendium of TB REACH case studies, lessons learned and a monitoring and evaluation framework.
Accessed November 2017.
Training for staff working at DR-TB management centres.
Training modules
PLoS ONE 12(7): e0180996. https://doi.org/10.1371/journal.pone.0180996
Selection and Use of Essential Medicines 2021
recommended
The 23rd meeting of the WHO Expert Committee on Selection and Use of Essential Medicines was coordinated from Geneva, Switzerland, and held virtually from 21 June to 2 July 2021. The Committee considered 88 applications proposing additions, changes and deletions of medicines, medicine classes and fo
...
